Literature DB >> 17053211

Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys.

Sercin Karahuseyinoglu1, Ozgur Cinar, Emine Kilic, Fadil Kara, Guvem Gumus Akay, Duygu Ozel Demiralp, Ajlan Tukun, Duygu Uckan, Alp Can.   

Abstract

Cells in the umbilical cord stroma have gained attention in recent years; however, differentiation to certain lineages in humans has been demonstrated in few studies. Unlike bone marrow MSCs, human umbilical cord stroma cells (HUCSCs) are far from being well characterized. This study attempts to describe proliferation, structural, and differentiation properties of these cells to account for their exceptional nature in many aspects. Cellular dynamics, cellular structure, and the degree of transformations during expansion and differentiation into mesenchymal and neuronal lineages were examined in vitro over a 10-month period. Comparisons with human bone marrow MSCs regarding differentiation were performed. HUCSCs in culture revealed two distinct cell populations, type 1 and type 2 cells, that possessed differential vimentin and cytokeratin filaments. Corresponding cells were encountered in cord sections displaying region-specific localization. alpha-Smooth muscle actin and desmin filaments, which were evident in cord sections, diminished through passages. No difference was noted regarding type 1 and type 2 cells in differentiation to chondrogenic, adipogenic, and osteogenic lineages, whereas a preferential differentiation was noted in neuronal lineage. Relative success was achieved by production of chondrocytic spheres and osteogenic monolayers, whereas adipocytes were immature compared with bone marrow MSCs. The presence of neuronal markers suggests that they transform into a certain state of maturity under neurogenic induction. Conclusively, HUCSCs retain their original phenotype in culture without spontaneous differentiation, have a limited lifespan, and bear multipotent stem cell characteristics. Given these characteristics, they may be generally considered progenitor cells if manipulated under appropriate conditions and deserve further study to be potentially used in cell-based therapies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17053211     DOI: 10.1634/stemcells.2006-0286

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  140 in total

Review 1.  Umbilical cord-derived mesenchymal stem cells: strategies, challenges, and potential for cutaneous regeneration.

Authors:  Siming Yang; Sha Huang; Changjiang Feng; Xiaobing Fu
Journal:  Front Med       Date:  2012-03-31       Impact factor: 4.592

Review 2.  Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues.

Authors:  Hassan Abdulrazzak; Dafni Moschidou; Gemma Jones; Pascale V Guillot
Journal:  J R Soc Interface       Date:  2010-08-25       Impact factor: 4.118

3.  ROCK inhibitor Y-27632 increases thaw-survival rates and preserves stemness and differentiation potential of human Wharton's jelly stem cells after cryopreservation.

Authors:  Kalamegam Gauthaman; Chui-Yee Fong; Arjunan Subramanian; Arijit Biswas; Ariff Bongso
Journal:  Stem Cell Rev Rep       Date:  2010-12       Impact factor: 5.739

4.  [Mesenchymal stem cells for bone tissue engineering].

Authors:  R K Schneider; S Neuss; R Knüchel; A Perez-Bouza
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

5.  Osteochondral interface tissue engineering using macroscopic gradients of bioactive signals.

Authors:  Nathan H Dormer; Milind Singh; Limin Wang; Cory J Berkland; Michael S Detamore
Journal:  Ann Biomed Eng       Date:  2010-04-09       Impact factor: 3.934

Review 6.  Musculoskeletal tissue engineering with human umbilical cord mesenchymal stromal cells.

Authors:  Limin Wang; Lindsey Ott; Kiran Seshareddy; Mark L Weiss; Michael S Detamore
Journal:  Regen Med       Date:  2011-01       Impact factor: 3.806

7.  Immunohistochemical and transcriptional expression of matrix metalloproteinases in full-term human umbilical cord and human umbilical vein endothelial cells.

Authors:  Annamaria Mauro; Maria Buscemi; Aldo Gerbino
Journal:  J Mol Histol       Date:  2010-10-10       Impact factor: 2.611

8.  Human umbilical cord mesenchymal stromal cells in a sandwich approach for osteochondral tissue engineering.

Authors:  Limin Wang; Liang Zhao; Michael S Detamore
Journal:  J Tissue Eng Regen Med       Date:  2010-12-30       Impact factor: 3.963

Review 9.  Neurotrauma and mesenchymal stem cells treatment: From experimental studies to clinical trials.

Authors:  Ana Maria Blanco Martinez; Camila de Oliveira Goulart; Bruna Dos Santos Ramalho; Júlia Teixeira Oliveira; Fernanda Martins Almeida
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

10.  Phenotypical and functional characteristics of mesenchymal stem cells derived from equine umbilical cord blood.

Authors:  N Mohanty; B R Gulati; R Kumar; S Gera; S Kumar; P Kumar; P S Yadav
Journal:  Cytotechnology       Date:  2014-12-09       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.